PEDIATRICS Vol. 117 No. 6 June 2006, pp. 2231-2243 (doi:10.1542/peds.2005-1919)
SPECIAL ARTICLE |
Neurodevelopment After Neonatal Hypoglycemia: A Systematic Review and Design of an Optimal Future Study
a Center for Pediatric Clinical Epidemiology
b Department of Neonatology, Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, Netherlands
OBJECTIVE. Our goal was to assess the effect of episodes of neonatal hypoglycemia on subsequent neurodevelopment.
METHODS. We searched Medline and Embase for cohort studies on subsequent neurodevelopment after episodes of hypoglycemia in the first week of life. Reference lists of available studies were reviewed, and content experts were contacted for additional studies. Included studies were selected and appraised for methodologic quality by 2 reviewers. Methodologic quality was assessed according to well-accepted criteria for prognostic studies. Eventually, all studies were given an overall quality score: poor, moderate, or high quality. Studies in the latter 2 categories were considered for quantitative data analysis.
RESULTS. Eighteen eligible studies were identified. The overall methodologic quality of the included studies was considered poor in 16 studies and high in 2 studies. Pooling of results of the 2 high-quality studies was deemed inappropriate because of major clinical and methodologic heterogeneity. None of the studies provided a valid estimate of the effect of neonatal hypoglycemia on neurodevelopment. Building on the strengths and weaknesses of existing studies, we developed a proposal for an "optimal" future study design.
CONCLUSIONS. Recommendations for clinical practice cannot be based on valid scientific evidence in this field. To assess the effect of neonatal hypoglycemia on subsequent neurodevelopment, a well-designed prospective study should be undertaken. We submit a design for a study that may answer the still-open questions.
Key Words: hypoglycemia prognosis developmental disabilities neonates systematic review research design
Abbreviations: LGAlarge for gestational age SGAsmall for gestational age AGAappropriate for gestational age DDSDenver Developmental Scale CIconfidence interval
Accepted Dec 10, 2005.
This article has been cited by other articles:
![]() |
H. Per, S. Kumandas, A. Coskun, H. Gumus, and D. Oztop Neurologic Sequelae of Neonatal Hypoglycemia in Kayseri, Turkey J Child Neurol, December 1, 2008; 23(12): 1406 - 1412. [Abstract] [PDF] |
||||
![]() |
M J J Finken, M G Keijzer-Veen, F W Dekker, M Frolich, F J Walther, J A Romijn, B J van der Heijden, J M Wit, and on behalf of the Dutch POPS-19 Collaborative Study Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F442 - F447. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Boluyt, D H G M Nuytemans, J H Kok, M Offringa, and A A M W van Kempen VARIATIONS IN DUTCH CLINICAL GUIDELINES FOR NEONATAL HYPOGLYCEMIA Arch. Dis. Child., November 1, 2008; 93(2_MeetingAbstracts): pw253 - pw253. |
||||







